The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus
That means they haven't gone through the same testing for safety, effectiveness, or quality
Instead, we strive to provide honest guidance based on the best available evidence, clinical experience, and each patient's individual circumstances while maintaining the strong belief that patients should have the freedom to make informed decisions about their care, including pursuing therapies that we, as clinicians, may not recommend.
The EMA has asked Novo Nordisk, which manufactures Ozempic, to add NAION to the list of side effects that can occur with very rare frequency. However, the US label for Ozempic does not contain this side effect
Satirapod, C
The primary difference is their number of targets